24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Destiny
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:00
Intel's Xeon 6 promises AI and network breakthroughs amid company struggles
15:15
DeepSeek’s AI disruption looms over Nvidia earnings report
13:05
Attention shoppers: Walmart trades at a higher multiple than Apple and Microsoft
12:40
Mylo’s “AI wingman” helps reignite a fatigued online dating scene
More stories
Buzz
Most popular
Daily
Weekly
1
‘It was through their lies that they became multimillionaires’: Charlie Javice fraud trial opens
2
AI won’t replace developers—but it will change who gets hired
3
Tel Aviv real estate reaches new peak at over $45,000 per sqm
4
Adi Dangot Zukovsky joins Ibex Investors as partner following fund’s leadership shift
5
Yad2 now valued at $420 million as investors line up for potential sale
More news
Destiny
2 stories about Destiny
The Destiny Fund isn’t beating the system - it's upholding it
21.04.24
|
Viki Auslender
The Destiny Tech100 fund is the latest fund that claims to connect unqualified investors with the leading private tech companies, claiming to offer new opportunities to allow us all to invest in major companies like angel investors. This isn’t the reality
Cannabis Companies Therapix and Destiny to Merge
28.07.19
|
Adi Pick
The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities